DENVER, CO / ACCESSWIRE / October 14, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced Josh ...
Vestibular Testing System MarketThe vestibular testing system market is projected to be valued at USD 119.3 million in 2023, with expectations to rise to USD 202.4 million by 2033, marking a ...
AQILION AB (publ) is developing the anti-inflammatory drug candidate AQ312 for the treatment of ulcerative colitis, and presents new results from the Aqilion preclinical development program at the ...